Annual Accounts Receivable
$26.87 M
+$357.00 K+1.35%
December 31, 2021
Summary
- As of February 10, 2025, CLVS annual accounts receivable is $26.87 million, with the most recent change of +$357.00 thousand (+1.35%) on December 31, 2021.
- During the last 3 years, CLVS annual accounts receivable has risen by +$13.98 million (+108.46%).
Performance
CLVS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$19.45 M
+$884.00 K+4.76%
September 30, 2022
Summary
- As of February 10, 2025, CLVS quarterly accounts receivable is $19.45 million, with the most recent change of +$884.00 thousand (+4.76%) on September 30, 2022.
- Over the past year, CLVS quarterly accounts receivable has dropped by -$6.32 million (-24.53%).
Performance
CLVS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CLVS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | -24.5% |
| 3 y3 years | +108.5% | +15.7% |
| 5 y5 years | +334.7% | +100.0% |
CLVS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -28.7% | -4.5% |
| 5 y | 5-year | at high | -23.5% | -28.7% | -6.4% |
| alltime | all time | at high | -99.5% | -28.7% | -100.0% |
Clovis Oncology Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $19.45 M(+4.8%) |
| Jun 2022 | - | $18.57 M(-32.0%) |
| Mar 2022 | - | $27.30 M(+1.6%) |
| Dec 2021 | $26.87 M(+1.3%) | $26.87 M(+4.2%) |
| Sep 2021 | - | $25.78 M(+6.6%) |
| Jun 2021 | - | $24.18 M(+11.3%) |
| Mar 2021 | - | $21.73 M(-18.0%) |
| Dec 2020 | $26.51 M(+28.9%) | $26.51 M(+30.8%) |
| Sep 2020 | - | $20.27 M(+11.3%) |
| Jun 2020 | - | $18.20 M(-27.4%) |
| Mar 2020 | - | $25.08 M(+22.0%) |
| Dec 2019 | $20.56 M | $20.56 M(+22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $16.82 M(+9.4%) |
| Jun 2019 | - | $15.38 M(-4.5%) |
| Mar 2019 | - | $16.10 M(+24.9%) |
| Dec 2018 | $12.89 M(+108.5%) | $12.89 M(-11.1%) |
| Sep 2018 | - | $14.49 M(+17.8%) |
| Jun 2018 | - | $12.30 M(-4.9%) |
| Mar 2018 | - | $12.94 M(+109.3%) |
| Dec 2017 | $6.18 M(+5008.3%) | $6.18 M(>+9900.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $1.14 M(-51.9%) |
| Mar 2017 | - | $2.38 M(+1865.3%) |
| Dec 2016 | $121.00 K | $121.00 K |
FAQ
- What is Clovis Oncology annual accounts receivable?
- What is the all time high annual accounts receivable for Clovis Oncology?
- What is Clovis Oncology annual accounts receivable year-on-year change?
- What is Clovis Oncology quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Clovis Oncology?
- What is Clovis Oncology quarterly accounts receivable year-on-year change?
What is Clovis Oncology annual accounts receivable?
The current annual accounts receivable of CLVS is $26.87 M
What is the all time high annual accounts receivable for Clovis Oncology?
Clovis Oncology all-time high annual accounts receivable is $26.87 M
What is Clovis Oncology annual accounts receivable year-on-year change?
Over the past year, CLVS annual accounts receivable has changed by +$357.00 K (+1.35%)
What is Clovis Oncology quarterly accounts receivable?
The current quarterly accounts receivable of CLVS is $19.45 M
What is the all time high quarterly accounts receivable for Clovis Oncology?
Clovis Oncology all-time high quarterly accounts receivable is $27.30 M
What is Clovis Oncology quarterly accounts receivable year-on-year change?
Over the past year, CLVS quarterly accounts receivable has changed by -$6.32 M (-24.53%)